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Abstract
Background: Chronic low back pain (CLBP) is a highly prevalent condition that has substantial impact on patients,
the healthcare system and society. Pain management services (PMS), which aim to address the complex nature of
back pain, are recommended in clinical practice guidelines to manage CLBP. Although the effectiveness of such
services has been widely investigated in relation to CLBP, the quality of evidence underpinning the use of these
services remains moderate. Therefore the aim is to summarize and critically appraise the current evidence for the
cost effectiveness of pain management services for managing chronic back pain.
Methods: Electronic searches were conducted in MEDLINE, EMBASE and PsycINFO from their inception to February
2019. Full economic evaluations undertaken from any perspective conducted alongside randomized clinical trials
(RCTs) or based on decision analysis models were included. Cochrane Back Review Group (CBRG) risk assessment
and the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist were used to assess the
methodological quality of eligible studies.
Results: Five studies fulfilled eligibility criteria. The interventions varied significantly between studies in terms of the
number and types of treatment modalities, intensity and the duration of the program. Interventions were compared
with either standard care, which varied according to the country and the setting; or to surgical interventions. Three
studies showed that pain management services are cost effective, while two studies showed that these services are not
cost effective.
In this review, three out of five studies had a high risk of bias based on the design of the randomised controlled trials
(RCTs). In addition, there were limitations in the statistical and sensitivity analyses in the economic evaluations.
Therefore, the results from these studies need to be interpreted with caution.
Conclusion: Pain management services may be cost effective for the management of low back pain. However, this
systematic review highlights the variability of evidence supporting pain management services for patients with back
pain. This is due to the quality of the published studies and the variability of the setting, interventions, comparators
and outcomes.
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Background
Low back pain is a common health condition; the esti-
mated global mean point prevalence is 11.9% [1]. In the
United Kingdom (UK), musculoskeletal pain is the leading
cause of chronic pain, with low back pain and osteoarthritis
together responsible for over half of all cases [2]. According
to the Health Survey for England [3], back pain was the
second most commonly reported site of pain. Low back
pain affects several life domains [4]. Patients with back pain
report limitation in daily activities such as work, housework
and leisure activities. Low back pain affects relationships,
increases feelings of loneliness, cohabitation problems, and
concerns surrounding sexual relations, and reduces social
interaction. Low back pain has been suggested to be the
leading cause of disability worldwide [5], with an associated
substantial economic burden. The indirect cost due to
productivity loss represent a large proportion of the overall
cost; a systematic review of 27 cost-of illness studies con-
ducted worldwide showed that back pain has a major
impact on indirect costs, which can represent 50 to 89% of
the total costs [6].
The biopsychosocial model is considered the most valid
framework in understanding and managing chronic low
back pain (CLBP) [7]. The model addresses pain as a com-
plex and dynamic interaction between physiological, social
and psychological elements. In order to manage pain within
a biopsychosocial framework a multidisciplinary manage-
ment approach to address these elements is required [8].
This model requires collaboration between healthcare pro-
fessionals from different specialties in order to deliver a
multidimensional and comprehensive treatment plan.
Combined physical and psychological treatment pro-
grams which fulfil the criteria of multidisciplinary pain
services have been recommended in clinical practice
guidelines, including in the UK, as a rational option for
managing people with CLBP [9, 10]. A recent systematic
review of the evidence for the clinical effectiveness of
multidisciplinary pain management services on clinically
relevant outcomes in CLBP examined 41 randomized
controlled trials (RCTs) targeting adults with CLBP for
more than 12 weeks [11]. The results demonstrated a
moderate effect in favour of the pain management ser-
vices (PMS) in improving disability and pain.
The cost-effectiveness of pharmacological treatments for
CLBP has been assessed by Haas et al. [12]. The systematic
review included seven economic evaluations, both model-
based and those carried out alongside RCTs. The results
highlighted variable quality of clinical effectiveness data
(RCTs), due to sample size not being sufficient to detect
differences in outcomes, or convenience sampling being
used in non-randomised studies. The quality of some of the
economic evaluations was affected by not clarifying the
study perspective or omitting to discount future costs or
benefits. The results from this review have limited relevance
to PMS due to fundamental differences between pharmaco-
logical and pain services due to combination of several
treatment modalities and their intensity.
Given the increasing prevalence of CLBP [1] and the
moderate effect size and perceived high delivery costs of
PMS [13], there is a need to critically appraise the cost-
effectiveness of these services to support stakeholders and
decision-makers in the commissioning and reimburse-
ment of PMS. The aim of this systematic review is to sum-
marise and critically appraise the current evidence for the
cost effectiveness of PMS in managing CLBP.
Methods
Types of studies
Full economic evaluations (i.e. cost effectiveness, cost mini-
misation, cost-benefit, cost utility and cost consequences
analysis), undertaken from any perspective and conducted
alongside RCTs or based on decision analysis models, were
included.
Partial economic evaluations, published protocols, con-
ference papers and observational studies, such as cohort,
case control and non-randomised studies, were excluded.
Types of participants
Studies including adults (age > 17 years) who had been re-
ferred to PMS from primary care with CLBP were eligible.
The Cochrane Back Review Group (CBRG) does not rec-
ommend mixing studies about acute and chronic low back
pain as the underlying causes differ and, therefore, re-
sponse to the intervention might be systematically different
[14] . Therefore, people with acute or sub-acute low back
pain lasting for less than 3 months were excluded. People
with low back pain caused by cancer, infection, cauda
equina syndrome or inflammatory disorders, such as spon-
dylitis, were excluded, as these types of people require in-
tensive and urgent assessment in secondary care.
Types of interventions
Although PMS have been recommended in clinical practice
guidelines, there is still no consensus around the exact def-
inition of these services [15]. Based on the systematic review
by Kamper et al. [11], PMS are defined as health services
targeting at least two of the social, physical, psychological
and/or occupational aspects provided by one or more
healthcare professionals. Given the wide range of terms used
to describe these services, we included all relevant terms in
our search strategy. The terms including multidisciplinary,
interdisciplinary, multimodal, multiprofessional, pain clinics
and rehabilitation clinic. An inclusive strategy was adopted
in order to identify all relevant publications and then a de-
tailed assessment of the service was undertaken.
PMS based in primary and secondary care were eligible.
The components of the services could include pharmaco-
logical treatments, physiotherapy, cognitive behavioural
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therapy, complementary medical approaches, such as acu-
puncture, and other relevant specialties, including rehabili-
tation medicine, occupational therapy and social services.
PMS that offered fewer than two treatment modalities
within the service were excluded.
Types of outcome measures
PMS can aim to either improve functional disability and
pain or focus on the vocational outcomes, such as return
to work. Therefore, the complex multidimensional aims
of these services require the measurement of a variety of
outcomes that best address the study aims and research
questions. Patient-reported outcomes, such as pain in-
tensity, functional disability, quality of life and return to
work, were assessed. Healthcare resource utilisation was
also examined.
Search methods for study identification
Electronic searches were conducted in MEDLINE,
EMBASE and PsycINFO from their inception to Febru-
ary 2019. The Health Technology Assessment Database
(HTA) in the Centre for Reviews and Dissemination
(CRD) were also searched. The NHS Economic Evalu-
ation Database (NHS EED) was searched from inception
to February 2016. Reference lists were checked to iden-
tify relevant publications.
The search was restricted to studies about humans
and published in English. The terms used in the search
strategy are listed in Additional file 1 .
Methodological quality assessment
The Consolidated Health Economic Evaluation Report-
ing Standards (CHEERS) checklist was used to assess the
methodological quality of reporting economic studies
[16]. Where the economic evaluation was linked to an
RCT, the 12-item checklist recommended by the CBRG
was used to assess the RCT’s risk of bias [14, 17]. This
tool addresses several domains related to a study’s in-
ternal validity. According to the CBRG guidelines [14,
17], a study is considered to have a “low risk of bias” if
at least six domains were categorised as having a low
risk of bias. Two reviewers (SA1 & SA2) screened the ti-
tles and abstracts and then one reviewer extracted the
data from the eligible studies. A third reviewer (RAE) re-
solved disagreements if necessary.
The extracted data from each study contained author
name, country, year, participant characteristics, interven-
tion, comparator and outcomes. Data allowing assess-
ment of risk of bias and adherence to CHEERS quality
criteria were extracted.
Results
The initial search retrieved 2744 publications. After re-
moving duplicates, and limiting to ‘English’ and ‘human’,
the results numbered 2019. Of the 2019 results, 1997
studies were judged, via the title and abstract, as not
relevant to the scope of this review. The flow chart dia-
gram of the included studies and the reason that studies
were excluded is presented in Fig. 1.
The remaining 22 full-text articles were assessed for
eligibility. Only five studies fulfilled our inclusion cri-
teria. Seventeen studies were excluded and details of the
excluded studies and the reasons for exclusion are de-
scribed in Additional file 2 .
Study characteristics
Five studies were included in the review; two studies were
conducted in Norway [18, 19], two in the Netherlands [20,
21] and one in the UK [22]. These studies were published
between 2002 and 2014. The characteristics of the in-
cluded studies are summarised in Table 1. The total num-
ber of participants in the five studies was 1023, with the
sample size ranging from 134 to 349 people. Two of the
studies only included adults in employment taking sick
leave due to CLBP [19, 20]. The mean age of the partici-
pants ranged from 41 to 45.5 years, with equal gender dis-
tributions. The mean duration of CLBP symptoms ranged
between 5 and 8 years.
A wide range of outcome measures were used in the
studies included in this review. Return-to-work (RTW)
was the primary outcome in three studies [19, 20, 22].
Four studies used two measures for disability [18, 20–
22]. Regarding the baseline measures of disease severity,
the mean functional disability score using the Roland
Morris Disability Score (RMDS) [23] was 14, the score
can range between 0 and 24 [20, 21]. Whereas the
Oswestry Disability Index (ODI) [24] mean score was 43
[18, 22], the ODI score ranges between 0 and 100. The
mean pain intensity score from the three studies was 5.8,
with the possible ranges of pain intensity being between
0 and 10 [18, 20, 21]. For all measures, the high scores
identify the greatest disability and pain. The mean EQ-
5D-3 L [25] score ranged from 0.26–0.49 [18, 21, 22]. A
generic health status measure, generally, the possible
ranges for the EQ-5D-3 L are between 0 and 1, where
high scores mean better health status. A further generic
health status measure, the Short Form 6D [26], was also
used in conjunction with EQ-5D-3 L in one study [18].
One study looked at costs from the patient and health-
care provider perspectives [22], while the remaining stud-
ies were conducted from the societal perspective [18–21].
The length of follow-up was between 12 and 24months.
The PMS consisted of combinations of cognitive be-
havioural therapy, physical therapy and workplace inter-
ventions. Two studies compared PMS with usual care
[19, 20], two with surgery [18, 22] and one with physical
treatment and graded activity (a treatment that includes
behavioural and cognitive methods to improve activity
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endurance) (two comparators) [21]. The outcomes were
return to work [19, 20], quality-adjusted life-years
(QALYs) using EQ-5D-3 L [18, 21, 22] and disability
using RMDQ [21] and ODI [18, 22].
Design and description of pain management services
The studies were delivered in a secondary care setting
only [18, 19, 22], primary care only [21], or a combined
setting [20]. All studies clearly described the service in
terms of treatment modalities and the staff involved in
delivering these services. However, in some studies the
duration of treatment varied between people within the
study [18, 20]. Among the included the duration ranged
between one and 3 months and the total number of hours
ranged between 3 and 75 h. In another study, the intensity
of treatment in terms of the total hours provided was not
consistent between individuals in the study [22]. Study
participants were generally working-age adults; two stud-
ies focused on employees with CLBP [19, 20] and no stud-
ies included people above 65 years old.
The description of services provided in the included
studies is summarised in Table 2.
The comparator
Two studies, which were conducted in the Netherlands and
Norway, compared PMS with “standard care” [19, 20]. In
Lambeek et al., standard care consisted of family physician
visits, in addition to occupational therapist consultations, pro-
vided in a primary care setting [20]. In Skouen et al., standard
care consisted of examination in the spine outpatient clinic
by a physician, followed by referral back to the GP [19].
Two studies compared the effect of PMS with surgery
[18, 22]. The surgical procedures were total disc replace-
ment [18] and spinal stabilisation [22]. As surgical options
Fig. 1 Flow Chart Diagram
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are usually reserved for the severest cases, the patient popu-
lations in these studies are likely to be different from those
where GP/medical management is offered as standard care
[19–21]. This is demonstrated by the increased pain inten-
sity and lower quality of life at baseline in the surgical stud-
ies [18, 22].. The mean baseline utility scores (EQ-5D) were
0.26 and 0.49 in studies assessing surgery [18] and non-
surgical treatments [21] as comparators, respectively. Simi-
larly, the baseline pain intensity score was 6.9 in the study
assessing surgery [18], while in the study assessing standard
care, the baseline score was 5.7 [20]. Therefore outcomes
achieved from referral to PMS are not comparable to other
studies due to higher baseline pain and disbility levels.
Methodological design
All of the economic evaluations were conducted along-
side RCTs. The risk of bias assessment of the included
studies is described in Table 3.
Two of the five studies were considered to have low
risk of bias [20, 21]. The major strengths in all of the in-
cluded studies were that the methods of randomisation
and allocation were clear. Moreover, intention-to-treat
Table 1 Characteristics of the included studies
Study ID Setting Target population/sample size Intervention Comparator(s)
Skouen 2002
[19] Norway
Outpatient
spine clinic
Patient sick listed for at least 8 weeks
or employees not on sick leave but
sick listed for at least 2 months /year
n = 195
Light multidisciplinary programme (assessment
by physiotherapist and psychologist + individual
education and feedback)
Extensive multidisciplinary programme (4-week
programme - 6 h session 5 days/week) consisting
of CBT, education, exercises, work place intervention)
Usual care
Rivero-Arias 2005
[22] United
Kingdom
Secondary care 18–55 years with CLBP > 1 year
n = 349
Intensive rehabilitation programme (education
+ exercise) led by a physiotherapist and clinical
psychologist
Spinal stabilisation
surgery
Smeets 2009
[21] Netherlands
Primary care Age between 18 and 65 years with
CLBP> 3months with RMD score >
3
n = 172
Active physical treatment + graded activity
+ problem training
2 comparators: active
physical treatment
and graded activity
plus problem training
Lambeek 2010
[20] Netherlands
Primary and
secondary care
Adults (18–65) with CLBP in paid
work for at least 8 h/week on
partial sick leave
n = 134
Integrated care programme (workplace
intervention + graded activity)
Usual care
Johnsen 2014
[18] Norway
Hospital Adults with CLBP > 1 year with
degenerative change in lumbosacral
intervertebral disc n = 173
Multidisciplinary rehabilitation (outpatient
programme focussed on exercise and CBT
delivered by a physiotherapist and physical
medicine specialist)
Total disc
replacement surgery
CLBP chronic low back pain, CBT cognitive behavioural therapy, RMD Roland Morris Disability
Table 2 Service description in the included studies
Study ID Staff delivering
the intervention
Intervention description Number of hours/day and
duration
Notes
Skouen 2002
[19] Norway
PT Nurse Psychologist
(if necessary)
Light intervention: Assessment, a
lecture, three individual sessions
and individually-based graded
exercise.
Assessment (1–2 h) Lecture (1 h)
Total for individual sessions (45
min)
Some people were offered visits
to an external PT, local National
Health Insurance and workplace
visits.
Extensive intervention:
Educational sessions, exercises
and (occasional) workplace
intervention
6 h, 5 days a week for 4 weeks.
Rivero-Arias 2005
[22] United Kingdom
PT and clinical
psychologist
Education Exercises and
hydrotherapy
5 days a week for 3 weeks The
total hours were 60–110 (75 h
on average)
One of the centres did not have
a psychologist or hydrotherapy
sessions.
Smeets 2009 [21]
Netherlands
PT Clinical psychologist
social worker
Physiotherapy Graded activity
with problem-solving training
Physiotherapy: 105 min three
times a week for 10 weeks
Graded activity: 19 sessions
starting from 3rd week.
Lambeek 2010
[20] Netherlands
OT physician PT OT
medical specialist
Workplace intervention
Graded activity
Graded activity (26 sessions)
for 3 months or until RTW
Coordinated
Johnsen 2014
[18] Norway
PT Specialist in
physical medicine
Lectures and individual
discussions Daily workout
60 h over 3–5 weeks Nurse, psychologist or social
worker as needed
PT Physiotherapist, OT Occupational therapist
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analysis was considered in the statistical analysis for
missing data.
High risk of bias was identified in three studies [18, 19,
22]. Two studies reported that the intervention group re-
ceived extra visits to physiotherapists and other healthcare
professionals compared with the standard care arm [21, 22].
Hence, the intervention group might have had better out-
comes, compared with standard care, because of these add-
itional visits. One of the important aspects in assessing the
quality of RCTs is the sample size and statistical power [27].
Four out of five studies were sufficiently powered (power
threshold 80%) to detect a difference in functional disability
using the ODI [18, 22], RMDS [21] or return to work [20].
Although all included studies incorporated RCTs, ran-
domisation by itself does not ensure that the baseline
characteristics of the study participants in the compara-
tor groups are similar [27]. Knowing this information is
essential to demonstrate that the participant response to
treatment is directly attributed to the intervention effect
and not to other patient-related factors. Adjusting effect
size for baseline characteristics should be performed
using statistical methods, generally regression. In our re-
view, only one study [21] performed regression to adjust
effect size for baseline characteristics. Furthermore, two
studies clearly reported that there was a significant dif-
ference between the study participants at baseline, which
they did not then go on to adjust [18, 19].
The quality of reporting economic evaluations in
terms of costs and outcomes is reported in Table 4,
while the details of sensitivity analysis and the results are
summarised in Table 5.
Healthcare resource use and cost
In this review, all of the studies included direct medical
and indirect costs. Four studies included direct non-
medical costs, such as travel expenses [18, 20–22]. Four
studies took the societal perspective [18–21] and one
study took the healthcare provider perspective [22]. Al-
though the last study stated that they conducted their
evaluation from a healthcare provider perspective, indir-
ect costs were calculated. Although Skouen et al. stated
that their study took a societal perspective [19], direct
non-medical costs were not collected.
There are two methods of assessing the service costs, the
top-down and the bottom-up (micro-costing) approaches
[28]. The top-down approach divides the total budget of a
health intervention by the total number of people to give
an “average” estimate of cost per patient, whereas the
bottom-up approach uses patient-level resource use data to
generate costs. The latter is the preferred method in eco-
nomic evaluations to account for variations in costs be-
tween study participants [28]. In this review, three studies
used the top-down approach [18, 19, 21], while two studies
used the bottom-up method [20, 22]. The method of col-
lecting costs was implied, rather than clearly stated, in three
studies [19, 21, 22]. Only two studies clearly reported all re-
source use and their unit costs [20, 21]. In two studies,
some unit costs were missing [18, 22] and Skouen et al. did
not report unit costs [19].
In this review, two studies used postal questionnaires to
collect resource use data from people [20, 22], which might
be subject to recall bias, especially if the recall period is
more than 3 months [29]. In Lambeek et al., the recall
Table 3 Risk of bias assessment according to the Cochrane Back Review Group (CBRG)
Risk of bias item Skouen
2002 [19]
Rivero-Arias
2005 [22]
Smeets
2009 [21]
Lambeek
2010 [20]
Johnsen
2014 [18]
Was the method of randomisation adequate? Low Low Low Low Low
Was the treatment allocation concealed? Low Unclear risk Low Low Low
Was the patient blinded to the intervention? Not possible
Was the care provider blinded to the intervention?
Was the outcome assessor blinded to the intervention?
Was the dropout rate described and acceptable? Low High Low Low Low
Did the analysis include intention-to-treat analysis? Low Low Low Low Low
Are the study reports free of suggestion of selective
outcome reporting?
Unclear risk Unclear risk Unclear risk High Unclear risk
Were the groups similar at baseline? Unclear risk Low Low Low High
Were co-interventions avoided? Unclear risk High High Unclear risk Unclear risk
Was the compliance acceptable in all groups? Unclear risk High High High Unclear risk
Was the timing of outcome assessment similar in two groups? Low Low Low Low Low
Summary risk of bias HIGH HIGH LOW LOW HIGH
Unclear = item not reported clearly
The study will be considered to have a low risk of bias if 6 or more items are satisfied, otherwise it will be considered to have a high risk of bias
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period was 3 months [20] while, in Rivero-Arias et al., the
recall period was 6 months and 1 year [22]. Two studies
used costing diaries to collect resource use data [18, 21].
Costing diaries aim to collect data prospectively, which re-
duces the risk of recall bias. To minimise the risk of incom-
pletion, regular telephone reminders are recommended but
neither of the studies using diaries reported providing re-
minders [18, 21].
Productivity loss due to illness can be accounted for by
absenteeism, the inability to attend work, and presentee-
ism, the reduced functionality in terms of quality and
quantity while working [30, 31]. Productivity loss can be
measured either objectively, by using attendance records,
or subjectively, using self-report by the employee [30].
These methods have some limitations; objective measures
might be inaccurate for assessing presenteeism, as they
only record employee attendance, with no emphasis on
productivity levels in terms of quality.
All studies assessed the effect of PMS on productivity
loss. Absenteeism was the only work outcome evaluated.
Four studies clearly reported their methods of collecting
productivity loss [19–22]. Although the appropriate recall
period is still inconclusive, 3 months’ recall for absenteeism
and 1 week for presenteeism is recommended [30]. Two
Table 5 Economic evaluation based on CHEERS criteria (statistical analysis and results)
Study ID Statistical analysis of cost data Statistical analysis
for missing data
Incremental economic
analysis reported
Sensitivity
analysis
Difference in
outcome
Difference in
costs
Difference in
outcome and
costs
Skouen 2002
[19] Norway
Not reported, only mean
difference in outcome
evaluated by ANOVA. RR
and 95% CI for the effect
of intervention versus
comparator on outcome.
Not reported productivity gain = NoK
7,858,100 - cost, the net
productivity gain = 240,900
Not
performed
Yes Not
reported
No
Rivero-Arias
[22] 2005 UK
Arithmetic mean for cost
and outcomes
Intention to treat and
multiple imputation
(variance correction)
Bootstrapping (1000
replications)
Yes No Yes Yes
Smeets 2009
[21] Netherland
student t test for change in
outcomes, linear regression to
adjust for baseline differences
Intention to treat
analysis, missing data
were replaced by
mean score of cost
and utility
Bootstrapping (1000
replications)
Yes No No No
Lambeek [20]
2010 Netherlands
Not reported Intention to treat
analysis, multiple
imputation
Bootstrapping (5000
replications)
Yes Yes Yes Yes
Johnsen 2014
[18] Norway
Student t test for cost
and utilities
Intention to treat
analysis, multiple
imputation
Bootstrapping (10,000
replications)
Yes Yes Yes Yes
ANOVA analysis of variance, RR relative risk, CI confidence interval, MDT multidisciplinary treatment, NoK Norwegian Krone
Table 4 Assessment of economic evaluations based on CHEERS criteria (inputs to economic evaluation: costs and outcomes)
Study ID Currency/year Direct cost Indirect costs Time
horizon
Health outcome Valuation of
preference outcomes
Skouen
2002 [19]
Norwegian Krone, price of
clinic in 1996, no inflation
Top down
approach
Yes 26 months Return to work NA (utilities were
not collected)
Rivero-Arias
2005 [22]
2002–2003 GBP inflated to
base year (2005)
Bottom up
approach
Yes. costing total
hours worked by
each patient
24 months Return to paid
employment,
total hours worked,
utility using EQ. 5D
Social tariff from
representative sample
of UK population
Smeets
2009 [21]
2003 Euros Top-down approach
and costing diaries
Yes, using human
capital approach
12 months Disability using
RMDQ,utility using
EQ. 5D
AUC, population and
techniques were not
described
Lambeek
2010 [20]
Index year 2007 (Euro converted
to GBP)
Bottom up
approach
Yes, using human
capital approach
12 months Return to work,
utilities using EQ.
5D
Dutch tariff however no
description of population
or methods used
Johnsen
2014 [18]
Norwegian Krone with 2006 as a
base year. Costs were adjusted for
inflation into 2012 prices and
converted to Euros using the
rate 1 € = 6.7 Kr2006
Top-down approach
and costing diaries
Yes, using human
capital approach
24 months Utilities using EQ.
5D and SF-6D
QALY was estimated as
AUC using trapezoidal
method. Population and
techniques were not
addressed.
AUC area under the curve, CE cost effectiveness, CB cost benefit, CU cost utility, QALY quality adjusted life years, EQ. 5D EuroQol 5 dimensions, SF-6D Short Form 6
dimension, GBP British pound, NA not applicable
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studies used “monthly” self-reported methods, utilis-
ing calendars [20] and diaries [21]. In another study
[22], the employment status was self-reported over a
relatively long period of 6 months and 1 year with in-
sufficient information about the measurement method
to assess quality. An objective measure was used in
one study [19], which utilised the national health
insurance registry to assess sickness absence. Johnsen
et al. [18] did not report the method of data
collection.
In order to value productivity loss among employees,
the “human capital approach” and the “friction cost
method” can be used [30]. As the friction cost approach
can produce lower estimates of cost, it is recommended
to use both approaches to determine any methods-
dervied difference. Four studies used the human capital
approach alone to value productivity loss [18–21]. In
Rivero-Arias et al. study the productivity was assessed by
calculating the total hours worked by each patient at
baseline, six,tweleve and 24 months [22].
Statistical analysis
The statistical analysis of patient-level cost data needs
to be adjusted from standard approaches as cost data
are generally “positively skewed”, because a small
number of people usually require more healthcare
resources [28, 32]. Non-parametric tests rely on me-
dians and distributional shape. Non-parametric boot-
strapping with replacement is the preferred method
to analyse cost data because it compares arithmetic
means while avoiding distributional assumptions.
Standard parametric tests can be used to analyse cost
data only if the sample size is large, where skewness
will not affect the validity of the analysis. Barber
et al. reported that, for sample sizes larger than 150
participants [33], the t-test is usually robust and valid,
as parametric assumptions will generally hold. In this
review, two studies used non-parametric bootstrap-
ping to test the difference in cost [20, 21], whereas
two studies with larger sample sizes, 349 [22] and
173 [18], used parametric t-tests for cost analysis.
Skouen et al. did not analyse differences in costs [19].
Discounting is used to estimate the future value of
outcomes and costs and assumes present outcomes
and costs are considered more valuable than those in
the future [28]. Future costs and outcomes should be
discounted where follow-up is longer than 1 year,
using nationally preferred discount rates. Lack of dis-
counting can lead to inaccuracy in estimating the
cost-effectiveness results. In this review, three studies
had interventions that continued for 2 years [18, 19,
22], two of which reported the discount rate accord-
ing to the country-specific rates [19, 22].
Dealing with uncertainty
The incremental cost effectiveness ratio (ICER) is the
main summary measure of an economic evaluation and is
the difference in cost divided by the difference in effect
(outcome) between two interventions [28]. The base case
analysis generates the ICER from the preferred outcome
and cost data. Sensitivity analysis is used to test the sensi-
tivity of the ICER to variation in cost and outcome param-
eters used in the base case analysis [28, 32]. In one-way
sensitivity analysis, one parameter is changed at a time to
test the results. Multiple-way analysis changes multiple
parameters at the same time. Although one-way sensitivity
analysis is easy and understandable, it can underestimate
total uncertainty in the ICERs [34].
Probabilistic sensitivity analysis (PSA) assumes that the
values of input cost and outcome variables have a probabil-
ity distribution. Probabilistic incremental economic analysis
is usually carried out using bootstrapping to generate cred-
ibility intervals that provide a quantitative measure of un-
certainty around ICER point estimates (“expected value”).
For the graphical representation of ICERs, cost effectiveness
planes are used to present the distribution of bootstrapped
ICERs [28]. Another common graphical presentation used
in economic evaluation is the cost effectiveness acceptabil-
ity curve (CEAC) [28]. The CEAC is a technique for repre-
senting information on uncertainty in cost-effectiveness. A
CEAC demonstrates the probability that an intervention is
cost-effective compared with the substitute, given the ob-
served data, for a range of maximum monetary thresholds
that policy makers are willing to pay for a specific unit
change in effect [35].
In this review, all studies carried out one-way sensitiv-
ity analysis. Four studies generated ICERs using boot-
strapping [18, 20–22] and three of them presented
ICERs on cost effectiveness planes [18, 20, 21]. CEACs
were used in these studies to present the probability of
cost effectiveness [18, 20–22].
Cost-effectiveness of PMS
The ICERs generated by the studies are summarised in
Table 6 . Only one study concluded that PMS dominates
usual care (more effective and less costly) [20]. Skouen
et al. concluded that multidisciplinary services are cost-
effective in men only [19]. However, this conclusion
needs to be interpreted with caution given that top-
down costs were used and there was no sensitivity or
statistical analyses reported. Two studies reported that
PMS are cheaper and less effective than surgery [18, 22].
Therefore, a trade-off between cost and effect needs to
be considered. Smeets et al. compared PMS with active
physical treatment (APT) and graded activity plus prob-
lem solving (GAP) [21]. In this study, the PMS was dom-
inated when compared with GAP, while it was cheaper
and less effective when compared with APT.
AlMazrou et al. BMC Health Services Research          (2020) 20:194 Page 8 of 11
Discussion
To our knowledge, this is the first systematic review that
summarises the current evidence regarding the cost-
effectiveness of PMS in CLBP.
This systematic review does not allow conclusive state-
ments about cost effectiveness of PMS to be made for a
number of reasons. Firstly, the complex and diverse nature
of the interventions, carried out in a range of settings meant
that the intervention itself was not a constant. Secondly, the
comparators among the included studies varied consider-
ably, affecting realtive costs and effects. Thirdly, patient co-
horts in each study were not necessarily comparable across
interventions, and, thus, the response to the PMS would
also be different. The inclusion criteria in some studies was
limited to working adults, which might limit the generalis-
ability of these services to the general population, which in-
clude homeworkers, the unemployed and older adults. A
trade-off between increasing the generalisibility of studies
while limiting the heterogenity by focusing on a specific
subset of people with CLBP need to be considered. This
could be achieved by using pragmatic RCTs.
In economic evaluation, generalizability is a major issue
that need to considered [36]. Several factors may attribute
to this limitation including clinical practice patterns, unit
costs and healthcare resources use which can be highly
varible across different countries and practice settings.
These challenges are augmented by the heterogeneity of
back pain, which is as a result of its complex underlying
aetiology and clinical course [37] and psychosocial factors
that might influence the progression of the condition.
In this review, three studies out of the five have a high
risk of bias, due to limitations in RCT methodological
design including clear adminstration of co-interventions
and variable compliance among groups. Trials of back
pain interventions often seem to have methodological
limitations leading to a high risk of bias [38]. A
Cochrane review of the effectiveness of PMS in CLBP in-
cluding 41 studies, of which 28 studies were considered
to have a high risk of bias [11].
In this review, all economic studies were conducted
alongside RCTs and the follow-up period ranged from
one to 2 years. Although this length of follow-up gives
some idea of the downstream medical cost and outcomes
associated with long-term treatment, ideally longer follow-
up (lifetime horizon) is needed. According to the MRC
recommendations for complex intervention evaluations
[39], a lifetime horizon is needed to demonstrate the sus-
tainability of short term changes in outcomes.
Several shortcomings were found in estimating the cost
of the PMS. Using a top-down approach gives the average
cost per patient; however, the method is not useful in
estimating the cost of people who consume healthcare
resources more or less than average patients do, such as
people with mild or severe conditions. Unit costs were ei-
ther poorly reported or not reported at all. In addition
methods for assessing indirect costs might be inaccurate
as presenteeism doesn’t take into account the employee
productivity [30].
Apart from methodological limitations in the economic
evaluation study design, terminology can be a problem
Table 6 Summary of incremental cost effectiveness analysis results
Study ID Intervention/Comparator Outcome
measure
Intervention
cost
Cost
difference
Outcome difference ICER
Skouen 2002
[19] Norway
Multidisciplinary treatment
vs usual care
Return
to work
NoK 9023 Not reported Net productivity gain
NoK 7,858,100 (USD
924500)
Net productivity gain = NoK
7,240,900(USD 852000)
Rivero-Arias
2005 [22] UK
Intensive rehabilitation
vs surgical stabilisation
QALY £1410 - £3304 - 0.068 48,588 £ per QALY (CE threshold
20,000-30,000£ per QALY)
Smeets 2009
[21] Netherland
Combined treatment vs
active physical treatment
RMDS Not reported - €456 - 1.23 371 € per one point reduction
in RMDS
QALY 0.014 35,060 € per QALY
Combined treatment vs
graded activity plus problem
solving
RMDS €4765 - 1.27 (dominated)
QALY - 0.045 (dominated)
Lambeek 2010
[20] Netherlands
Integrated care vs usual care Return to
work (days)
£1077 £217 (direct
cost)
- 68 -3a £ per 1 day earlier
return to work
QALY - £5310
(total cost)
0.09 (dominant)
Johnsen 2014
[18] Norway
Multidisciplinary rehabilitation
vs total disc replacement
QALY using
EQ-5D
€5977 - €13,506 - 0.34 39748a € per QALY
QALY using
SF-6D
0.11 128,328 € per QALY (CE
threshold €74,600 per QALY)
aCost effective, NoK Norwegian Krone, QALY quality adjusted life years, USD United States Dollar
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when conducting systematic reviews of complex inter-
ventions [40]. Service terminology is highly variable
across different settings, countries and clinical contexts
and this factor might increase the difficulty in searching
and identifying relevant publications. Researchers who
are interested in conducting systematic reviews in com-
plex interventions need to select either a search strategy
that gathers a wide range of heterogeneous studies to
inform the literature about factors that influence this
heterogeneity and, thus, address these limitations for
future research, or use strict search criteria that define
the intervention clearly, which can result in a robust
conclusion. However, conducting such a review might
be difficult when researchers use different terminology.
In addition, narrowing the research might result in a
small number of studies, given that the type and inten-
sity of treatments provided within PMS are highly vari-
able. The chance of finding studies that have an
identical service, in terms of staff, disciplines involved,
duration and intensity, is unlikely.
In this systematic review, a broad search criterion
was chosen to conduct the systematic review because
the main objective was to investigate the cost effect-
iveness of the PMS regardless of the type or the
intensity of the treatments provided. Although it is
logical to compare interventions that have the same
components to assess cost effectiveness, it is rare to
find studies comparing a matching intervention.
Given these challenges, inconclusive results about
the cost effectiveness of these services arise from the
variability and heterogeneity of the services and the
condition respectively, which makes comparison
between studies difficult. The other issue is the poor
quality of RCTs, which are the source of “effective-
ness data” in economic evaluation, leading to weak
cost effectiveness results. Finally, the limitations in es-
timating the cost of services and the short follow-up
period affect the results of the economic evaluations.
The economic evaluations identified in this review
were alongside RCTs with short follow-up periods,
which is insufficient to assess the long term benefit of
the service. Decision analysis models, which usually have
lifetime cost effectiveness data, were lacking.
Conclusion
PMS might be cost effective in the management of
CLBP. However, this systematic review highlights the
discrepancies in the evidence supporting PMS for people
with CLBP due to the variability of the setting, interven-
tions, comparators and outcomes. Therefore, more site
specfic and better studies are needed. Research direc-
tions should focus on optimising the methods of asses-
sing healthcare resource use and cost in order to
improve the analysis in the future. In addition, well
conducted RCTs with low risk of bias are needed. Fi-
nally,assessing the long terms benefits of these services
by conducting pragmatic RCTs combined with model-
based economic evaluations is warrented.
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